We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Iron Status Determined in Pregnancy Using the Thomas Plot

By LabMedica International staff writers
Posted on 12 Jan 2016
Print article
The Advia Centaur XP immunoassay system
The Advia Centaur XP immunoassay system (Photo courtesy of Siemens Healthineers - Laboratory Diagnostics)
Iron deficiency anemia (IDA) in pregnancy is common and associated with an increased risk for poor pregnancy outcomes, including intrauterine growth retardation, stillbirth, preterm delivery, low birthweight, and decreased survival of peripartum hemorrhage.

Physiological changes during pregnancy affect routine tests for iron deficiency. The reticulocyte hemoglobin equivalent (RET-He) and serum-soluble transferrin receptor (sTfR) assay are newer diagnostic parameters for the detection of iron deficiency, combined in the Thomas diagnostic plot.

Hematologists at the University of the Free State (Bloemfontein, South Africa) recruited for a study 103 participants, ranging between 18 and 42 years in age (median 24 years), and 50 were primigravidae. The gestation at which they presented for their first antenatal visit varied greatly from five to 36 week and the median gestational age was 18 weeks. Most of the participants (61.1%) were in their second trimester of pregnancy (13- to 28-week gestation) and 32% of participants were human immunodeficiency virus (HIV)-positive.

A full blood count (FBC) with reticulocyte parameters (RET-He) was performed using the Sysmex XE-2100 analyzer (Sysmex Corporation; Kobe, Japan). Serum ferritin was measured on the Advia Centaur XP immunoassay system (Siemens Healthcare Diagnostics Inc.; Tarrytown, NY, USA). The sTfR was determined using the Siemens subsidiary Dade Behring N Latex sTfR kit on a Siemens BN Prospec System nephelometer, and the C-reactive protein (CRP) was measured using the Synchron LX20 instrument and Synchron CRP reagent kit (Beckman Coulter; Fullerton, CA, USA).

The scientists found that according to the Thomas plot, 72.8% of the participants had normal iron stores and erythropoiesis. Iron-deficient erythropoiesis was detected in 12.6%. A third of participants were anemic. Serum ferritin showed excellent sensitivity but poor specificity for detecting depleted iron stores. Participants in their first trimester of pregnancy were less likely to have iron-deficient erythropoiesis and functional iron deficiency than participants in the third trimester. HIV status had no influence on the iron status of the participants.

The authors concluded that their findings reiterate that causes other than iron deficiency should be considered in anemic individuals. When compared with the Thomas plot, a low serum ferritin is a sensitive but nonspecific indicator of iron deficiency. The Thomas plot may provide useful information to identify pregnant individuals in whom hematological parameters indicate limited iron availability for erythropoiesis. The study was first published online on November 14, 2015, in the International Journal of Laboratory Hematology.

Related Links:

University of the Free State 
Sysmex Corporation 
Siemens Healthcare Diagnostics Inc. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.